Verastem (VSTM) Equity Average (2018 - 2025)

Historic Equity Average for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $10.3 million.

  • Verastem's Equity Average fell 3136.3% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 3136.3%. This contributed to the annual value of $67.5 million for FY2022, which is 3346.74% down from last year.
  • As of Q3 2025, Verastem's Equity Average stood at $10.3 million, which was down 3136.3% from $1.8 million recorded in Q2 2025.
  • Verastem's Equity Average's 5-year high stood at $108.9 million during Q1 2021, with a 5-year trough of -$30.7 million in Q1 2025.
  • Moreover, its 5-year median value for Equity Average was $56.8 million (2022), whereas its average is $50.5 million.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 6740.01% in 2021, then plummeted by 15665.64% in 2025.
  • Quarter analysis of 5 years shows Verastem's Equity Average stood at $91.6 million in 2021, then crashed by 39.82% to $55.1 million in 2022, then skyrocketed by 67.57% to $92.4 million in 2023, then tumbled by 109.65% to -$8.9 million in 2024, then skyrocketed by 215.12% to $10.3 million in 2025.
  • Its Equity Average was $10.3 million in Q3 2025, compared to $1.8 million in Q2 2025 and -$30.7 million in Q1 2025.